BioHarvest Sciences Inc. Common Stock (BHST) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BioHarvest Sciences Inc. Common Stock (BHST) has a cash flow conversion efficiency ratio of -0.068x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.58 Million) by net assets ($23.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BioHarvest Sciences Inc. Common Stock defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
BioHarvest Sciences Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how BioHarvest Sciences Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
BioHarvest Sciences Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioHarvest Sciences Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Formosa Electronic Industries
TWO:8171
|
-0.016x |
|
Arena Group Holdings Inc
NYSE MKT:AREN
|
-2.718x |
|
Dominari Holdings Inc.
NASDAQ:DOMH
|
-0.917x |
|
Fecon Foundation Engineering and Underground Construction JSC
VN:FCN
|
0.089x |
|
Heron Therapeuti
NASDAQ:HRTX
|
-0.169x |
|
Ardea Resources Ltd
AU:ARL
|
-0.022x |
|
Optex Systems Holdings, Inc. Common Stock
NASDAQ:OPXS
|
-0.047x |
|
Anfield Resources Inc
V:AEC
|
-0.103x |
Annual Cash Flow Conversion Efficiency for BioHarvest Sciences Inc. Common Stock (2019–2025)
The table below shows the annual cash flow conversion efficiency of BioHarvest Sciences Inc. Common Stock from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see BioHarvest Sciences Inc. Common Stock (BHST) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $25.45 Million | $-7.23 Million | -0.284x | +94.35% |
| 2024-12-31 | $1.33 Million | $-6.68 Million | -5.026x | -975.91% |
| 2023-12-31 | $-14.85 Million | $-8.52 Million | 0.574x | -63.19% |
| 2022-12-31 | $-5.93 Million | $-9.24 Million | 1.559x | +165.50% |
| 2021-12-31 | $2.85 Million | $-6.79 Million | -2.380x | -240.94% |
| 2020-12-31 | $-2.29 Million | $-3.88 Million | 1.688x | +1810.94% |
| 2019-12-31 | $-26.97 Million | $-2.38 Million | 0.088x | -- |
About BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and w… Read more